Family owned & operated with over 30 locations,
along the East Coast & Central Florida, to serve you!


Empowering you to take action sooner

Hearing loss is the leading preventable risk factor for cognitive decline. Studies show that individuals with untreated hearing loss face a 42% higher risk of developing dementia. Dementia and hearing loss are widespread, with around 6 million people in the United States diagnosed with Alzheimer’s, accounting for 60-70% of all dementia cases. Additionally, about 48 million Americans experience varying degrees of hearing loss.

The Cognivue Thrive® device offers a swift and simple cognitive screening method, delivering concrete data to help you TAKE ACTION SOONER. This test detects potential cognitive impairment so that can address modifiable risk factors to potentially change the course of the impairment. Cognivue is the world's first FDA-cleared computerized test of cognitive function

Research consistently demonstrates that auditory health directly influences cognitive function, with individuals experiencing hearing impairment often showing signs of cognitive decline at an earlier age compared to those with standard hearing levels. A notable investigation by researchers at John Hopkins, involving a six-year observation of 2,000 older adults, revealed that hearing loss significantly accelerates cognitive decline.

At Beltone, we understand the intricate relationship between hearing loss and cognitive health. We emphasize the importance of hearing care in the early identification of cognitive impairments.

Beltone unveils tech to test hearing and cognitive abilities

Palatka is one of eight Florida cities housing a new technology designed to assess a person’s cognitive abilities and take medical action from there. The Cognivue test rolled out in February 2024.

Want to test your cognitive health? Call or fill out this form and we will reach out to you immediately!
  • This field is for validation purposes and should be left unchanged.